Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: A case series

British Journal of Oral and Maxillofacial Surgery

Volumn 51, Issue 8, 2013, Pages 874-879

  Lopez Cedrun J L ^a   Sanroman J F ^b   Garcia A ^c   Penarrocha, M ^d   Feijoo, J F ^c   Limeres, J ^c   Diz, P ^c  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b Department of Oral and Maxillofacial Surgery   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Dental implant; Oral bisphosphonate; Osteonecrosis of the jaws

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID; RISEDRONIC ACID; BONE DENSITY CONSERVATION AGENT; CORTICOSTEROID; ETIDRONIC ACID; TOOTH IMPLANT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; JAW OSTEONECROSIS; MALE; MANDIBLE IMPLANT; MOUTH CAVITY; OSTEOARTHRITIS; OSTEOPOROSIS; RHEUMATIC POLYMYALGIA; TOOTH IMPLANT; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; CLINICAL TRIAL; COMPLICATION; HYPERTENSION; MANDIBULAR DISEASES; MAXILLARY DISEASES; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY; RISK FACTOR; TIME;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; AGED; ALENDRONATE; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; DENTAL IMPLANTS; DIPHOSPHONATES; ETIDRONIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MANDIBULAR DISEASES; MAXILLARY DISEASES; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84889887120     PISSN: 02664356     EISSN: 15321940     Source Type: Journal    
DOI: 10.1016/j.bjoms.2013.06.011     Document Type: Article

References (24)

1. G.A. Rodan, and A.A. Reszka Bisphosphonate mechanism of action Curr Mol Med 2 2002 571 577
2. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 65 2007 369 376
3. S. Otto, M.H. Abu-Id, and S. Fedele Osteoporosis and bisphosphonates- related osteonecrosis of the jaw: not just a sporadic coincidence - a multi-centre study J Craniomaxillofac Surg 39 2011 272 277
4. N. Yarom, R. Yahalom, Y. Shoshani, W. Hamed, E. Regev, and S. Elad Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome Osteoporosis Int 18 2007 1363 1370
5. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117
6. W.J. Starck, and B.N. Epker Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report Int J Oral Maxillofac Implants 10 1995 74 78
7. C. Madrid, and M. Sanz What influence do anticoagulants have on oral implant therapy? A systematic review Clin Oral Implants Res 20 Suppl. 4 2009 96 106
8. F. Javed, and K. Almas Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review J Periodontol 81 2010 479 484
9. S.L. Ruggiero, T.B. Dodson, and L.A. Assael American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update J Oral Maxillofac Surg 67 2009 2 12
10. B.J. Edwards, J.W. Hellstein, and P.L. Jacobsen Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs J Am Dent Assoc 139 2008 1674 1677 [Erratum: J Am Dent Assoc 2009;140:322]
11. M.M. Bornstein, N. Cionca, and A. Mombelli Systemic conditions and treatments as risks for implant therapy Int J Oral Maxillofac Implants 24 Suppl. 2009 12 27
12. C.E. Sverzut, A.T. Sverzut, F.P. de Matos, R.B. Kato, A.E. Trivellato, and P.T. de Oliveira Mandibular bisphosphonate-related osteonecrosis after dental implant rehabilitation: a case report Implant Dent 21 2012 449 453
13. T.-G. Kwon, C.-O. Lee, J.-W. Park, S.-Y. Choi, G. Rijal, and H.-I. Shin Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment Clin Oral Implants Res 2012 10.1111/clr.12088 [Epub ahead of print]
14. T.S. Lazarovici, R. Yahalom, S. Taicher, D. Schwartz-Arad, O. Peleg, and N. Yarom Bisphosphonate-related osteonecrosis of the jaw associated with dental implants J Oral Maxillofac Surg 68 2010 790 796
15. C. Jacobsen, P. Metzler, M. Rossle, J. Obwegeser, W. Zemann, and K.W. Gratz Osteopathology induced by bisphosphonates and dental implants: clinical observations Clin Oral Investig 7 2013 167 175
16. D.C. Martin, F.S. O'Ryan, and A.T. Indresano Characteristics of implant failures in patients with a history of oral bisphosphonate therapy J Oral Maxillofac Surg 68 2010 508 514
17. A. Goss, M. Bartold, P. Sambrook, and P. Hawker The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series J Oral Maxillofac Surg 68 2010 337 343
18. B.T. Grant, C. Amenedo, K. Freeman, and R.A. Kraut Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases J Oral Maxillofac Surg 66 2008 223 230
19. M.K. Jeffcoat Safety of oral bisphosphonates: controlled studies on alveolar bone Int J Oral Maxillofac Implants 21 2006 349 353
20. P.A. Fugazzotto, W.S. Lightfoot, R. Jaffin, and A. Kumar Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices J Periodontol 78 2007 1664 1669
21. B.M. Bell, and R.E. Bell Oral bisphosphonates and dental implants: a retrospective study J Oral Maxillofac Surg 66 2008 1022 1024
22. M. Diniz-Freitas, J.L. López-Cedrún, J. Fernández-Sanromán, A. García-García, J. Fernández-Feijoo, and P. Diz-Dios Oral bisphosphonate-related osteonecrosis of the jaws: clinical characteristics of a series of 20 cases in Spain Med Oral Patol Oral Cir Bucal 17 2012 e751 e758
23. P.K. Palaska, V. Cartsos, and A.I. Zavras Bisphosphonates and time to osteonecrosis development Oncologist 14 2009 1154 1166
24. P. Diz, J. Limeres, S. Fedele, J. Seoane, M. Diniz, and J.F. Feijoo Is oral bisphosphonate-related osteonecrosis of the jaw an endemic condition? Med Hypotheses 78 2012 315 318